Hecht Peter M 4
4 · Cyclerion Therapeutics, Inc. · Filed Jan 24, 2022
Insider Transaction Report
Form 4
Hecht Peter M
Director10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-03+52,950→ 52,950 totalExercise: $1.78Exp: 2032-01-03→ Common Stock (52,950 underlying) - Award
Employee Stock Option (Right to Buy)
2022-01-20+430,000→ 430,000 totalExercise: $1.21Exp: 2032-01-20→ Common Stock (430,000 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable as to 8.33333% of the shares of Common Stock on each monthly anniversary of January 3, 2022.
- [F2]The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022.